Global Injectable Drug Delivery Market is expected to reach USD 789.7 billion by 2024 from USD 330.6 billion in 2016, at a CAGR of 11.5% in the forecast period 2017 to 2024. The new market report contains data for historic years 2015, the base year of calculation is 2016 and the forecast period is 2017 to 2024.
Injectable Drug Delivery Market – Market Segmentation:
Injectable drug delivery device market is segmented into conventional injection devices and self-injection devices. The injectable drug delivery formulation is segmented into conventional drug delivery formulation and novel drug delivery formulation.
On the basis of application, the market is segmented into autoimmune disease, hormonal disorders, orphan diseases, oncology and others. The autoimmune diseases segment is further sub segmented based on indications into rheumatoid arthritis, multiple sclerosis, Crohn’s disease, psoriasis and others. Hormonal disorders are further segmented into indications such as diabetes, antithrombotic therapy, reproductive health diseases, anemia, osteoporosis and others.
On the basis of usage pattern, the market is segmented into curative care, immunization and other usage pattern.
On the basis of mode of administration, the market is segmented into skin, circulatory/muskoskeletal, organs and central nervous system.
On the basis of end users, the market is classified into hospitals and clinics, home healthcare, research laboratories, pharmaceutical and biotechnological companies and others. In 2017, the hospital &clinics segment is expected to dominate the market and is expected to continue this trend till 2024.
Browse Full Report with Details TOC @ http://databridgemarketresearch.com/reports/global-injectable-drug-delivery-market/
Based on geography, the market is segmented into five geographical regions:
- North America
- South America
- Middle East and Africa
The geographical regions are further segmented into 29 major countries such as U.S. Canada, Mexico, Germany, France, U.K., Belgium, Switzerland, Belgium, Turkey, Japan, China, Singapore, Brazil, India, Russia, South Africa and others.
Some of the major players operating in this market are
Becton Dickinson and company is going to dominate the injectable drug delivery market following with Pfizer and Baxter International, Inc., along with others such as Gerresheimer AG, Schott AG, Alkermes Plc., Eli Lilly and Company, Sandoz, Terumo Corporation, Teva Pharmaceuticals Industries Ltd., Bespak, Antares Pharma,Elcam Medical, Haselmeier, Mylan N.V., Novo Nordisk, Owen Mumford Ltd, Sanofi, West Pharmaceutical Services, Inc, Ypsomed Holding AG.
Global Hemostats Market- Trends and Forecast to 2024
Global Hemostats Market, By Product Type (Thrombin Based, Combination, Oxidized Regenerated Cellulose Based, Gelatin Based, Collagen Based Hemostat), By Indication (Wound Closure, Surgery), By End-User (Hospitals, Clinics, Ambulatory Centers, Community Healthcare, Others), By Geography (North America, South America, Europe, Asia-Pacific, Middle East and Africa) – Trends and Forecast to 2024
About Data Bridge Market Research:
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.
Data Bridge Market Research
Visit Blog http://databridgemarketresearch.com/blog/
Company Name: Data Bridge Market Research Private Limited
Contact Person: Vishal Dixit
Email: Send Email
Address:Office Number 317, Amanora Chambers, Magarpatta Road, Hadapsar